Maravai LifeSciences · ISIN: US56600D1072

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

TriLink BioTechnologies® (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research — starting with a significant donation to top academic labs across the U.S. and Europe. The donation commemorates the launch of TriLink’s first mRNA synthesis kit featuring CleanCap® capping technology, an all-in-one kit wit...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

This news feed is a compilation of company-relevant news from the most popular and widest-reaching newswire services. The feed is updated several times. For market-related publications, we recommend the X-Billboard, the Daily News Digest or our Premium Information Service.
Most recent update: 20.05.2025 | 14:00
20 May 2025 02:00PM
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
TriLink BioTechnologies® (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research — starting with a significant donation to top academic labs across the U.S. and Europe. The donation commemorates the launch of TriLink’s first mRNA synthesis kit featuring CleanCap® capping technology, an all-in-one kit wit...
Maravai LifeSciences
© BusinessWire
14 May 2025 10:00PM
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
Today, TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit international organization devoted to and the discovery, development and delivery of vaccines for global health signed a Memorandum of Under...
Maravai LifeSciences
© BusinessWire
05 May 2025 05:10PM
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) (NASDAQ: MRVI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange...
Maravai LifeSciences
© BusinessWire
05 May 2025 03:45PM
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) and reminds investors of the May 5, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company...
Maravai LifeSciences
© BusinessWire
05 May 2025 03:09PM
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, May 5, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunde...
Maravai LifeSciences
© PR Newswire
05 May 2025 11:47AM
MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI
LOS ANGELES, May 5, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) for violations of the federal securities laws....
Maravai LifeSciences
© PR Newswire
05 May 2025 11:45AM
The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRVI
NEW YORK, May 5, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed ar...
Maravai LifeSciences
© PR Newswire
02 May 2025 11:45AM
Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
NEW YORK, May 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINITI...
Maravai LifeSciences
© PR Newswire
02 May 2025 01:44AM
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like to discuss your...
Maravai LifeSciences
© PR Newswire
01 May 2025 11:45AM
Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
NEW YORK, May 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed ar...
Maravai LifeSciences
© PR Newswire
30 April 2025 11:55PM
MRVI Deadline: MRVI Investors with Losses in Excess of $100K Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
NEW YORK, April 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025...
Maravai LifeSciences
© PR Newswire
30 April 2025 06:00PM
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, April 30, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI)....
Maravai LifeSciences
© PR Newswire
29 April 2025 06:00PM
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, April 29, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI) have opportunity to lead the securities fraud class action lawsuit....
Maravai LifeSciences
© PR Newswire
29 April 2025 11:45AM
Maravai LifeSciences Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
NEW YORK, April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFIN...
Maravai LifeSciences
© PR Newswire
28 April 2025 10:15PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
NEW YORK, April 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inqui...
Maravai LifeSciences
© PR Newswire
28 April 2025 11:45AM
Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact The Gross Law Firm about pending Class Action - MRVI
NEW YORK, April 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed...
Maravai LifeSciences
© PR Newswire
28 April 2025 07:48AM
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereu...
Maravai LifeSciences
© PR Newswire
27 April 2025 04:20PM
MRVI Deadline: Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025. Maravai is a life sciences company which provides products to enable the development of drug therapies...
Maravai LifeSciences
© BusinessWire
25 April 2025 08:17PM
MRVI Deadline: MRVI Investors with Losses in Excess of $100K Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
NEW YORK, April 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025...
Maravai LifeSciences
© PR Newswire
25 April 2025 11:45AM
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) - May 5, 2025 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, April 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFIN...
Maravai LifeSciences
© PR Newswire
24 April 2025 06:00PM
Deadline Approaching: Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa., April 24, 2025 /PRNewswire/ -- ­­Law Offices of Howard G. Smith reminds investors of the upcoming May 5, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI) securities between August 7, 2024 and February...
Maravai LifeSciences
© PR Newswire
24 April 2025 11:45AM
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights - MRVI
NEW YORK, April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed...
Maravai LifeSciences
© PR Newswire
22 April 2025 11:21PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
NEW YORK, April 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inqui...
Maravai LifeSciences
© PR Newswire
22 April 2025 11:45AM
Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
NEW YORK, April 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFIN...
Maravai LifeSciences
© PR Newswire
21 April 2025 03:40PM
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereu...
Maravai LifeSciences
© PR Newswire
21 April 2025 11:45AM
The Gross Law Firm Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
NEW YORK, April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed...
Maravai LifeSciences
© PR Newswire
21 April 2025 02:10AM
Maravai LifeSciences Holdings, Inc. (MRVI) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds MRVI Investors of Securities Fraud Class Action Lawsuit
RADNOR, Pa., April 20, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai") (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7,...
Maravai LifeSciences
© PR Newswire
20 April 2025 07:10PM
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
NEW YORK, April 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025...
Maravai LifeSciences
© PR Newswire
18 April 2025 11:45AM
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRVI
NEW YORK, April 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFIN...
Maravai LifeSciences
© PR Newswire
17 April 2025 11:45AM
Maravai LifeSciences Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights - MRVI
NEW YORK, April 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed...
Maravai LifeSciences
© PR Newswire
17 April 2025 02:00AM
Kirby McInerney LLP Urges Investors in Maravai Lifesciences Holdings, Inc. to Inquire About Their Rights in Class Action Lawsuit
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI) securities during the period from August 7, 2024, through February 24, 202...
Maravai LifeSciences
© BusinessWire
16 April 2025 06:00PM
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, April 16, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI)....
Maravai LifeSciences
© PR Newswire
16 April 2025 02:12AM
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
NEW YORK, April 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025...
Maravai LifeSciences
© PR Newswire
16 April 2025 01:46AM
Maravai LifeSciences Holdings, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., April 15, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai") (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7...
Maravai LifeSciences
© PR Newswire
15 April 2025 10:22PM
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, April 15, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI) have opportunity to lead the securities fraud class action lawsuit....
Maravai LifeSciences
© PR Newswire
15 April 2025 04:08PM
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like to discuss your...
Maravai LifeSciences
© PR Newswire
15 April 2025 03:35PM
MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI
LOS ANGELES, April 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) for violations of the federal securities laws....
Maravai LifeSciences
© PR Newswire
14 April 2025 10:14PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inqu...
Maravai LifeSciences
© PR Newswire
14 April 2025 03:04PM
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 14, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereu...
Maravai LifeSciences
© PR Newswire
11 April 2025 11:45AM
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, April 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFIN...
Maravai LifeSciences
© PR Newswire
10 April 2025 08:58PM
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
NEW YORK, April 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025...
Maravai LifeSciences
© PR Newswire
10 April 2025 06:00PM
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa., April 10, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MARAVAI LIFESCI...
Maravai LifeSciences
© PR Newswire
10 April 2025 04:34PM
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If purchased or acquired securities in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like to discuss your legal rights, call Faru...
Maravai LifeSciences
© PR Newswire
10 April 2025 03:19PM
Maravai LifeSciences Holdings, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., April 10, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai") (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7,...
Maravai LifeSciences
© PR Newswire
10 April 2025 11:45AM
The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRVI
NEW YORK, April 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed...
Maravai LifeSciences
© PR Newswire
08 April 2025 04:00PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
NEW YORK, April 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inqui...
Maravai LifeSciences
© PR Newswire
08 April 2025 03:54PM
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, April 8, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereun...
Maravai LifeSciences
© PR Newswire
08 April 2025 11:45AM
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Maravai LifeSciences Holdings, Inc.(MRVI) Shareholders
NEW YORK, April 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINI...
Maravai LifeSciences
© PR Newswire

The information service offers company-relevant news from leading newswire services in a compact form for a quick overview. When the detailed view is called up, further information can be accessed if required. The navigation elements in previewer mode allow you to quickly switch to the most frequently visited tool sections. From there, you can access further areas that can be used for your own research and analysis. Tip: The information platform now includes more than 50 mini-apps developed in-house.

AI First: Feel free to test the AI integration that will quickly put you on a par with financial journalists and research houses

Further information

The information presented in this section is secondary publications. The content corresponds to the source information. You can find information on the author of the news item in the detailed information of a publication. News relating to listed companies may have been created due to regulatory publication obligations, due to regular public relations work for PR or marketing reasons or by third parties against the background of investor information.

The combination of information and graphic elements contributes significantly to visual orientation and navigation through complex issues. This makes it easier to grasp, contextualize and process key content. Images, logos and other or comparable graphic and textual elements used on the information portal are used for visual navigation, are part of the original message or have illustrative purposes. All rights to these elements are held by the respective owners of the trademark or image rights. They are used without intent to infringe copyright or intellectual property rights. Image material provided via the distribution networks is treated as part of the original message and processed accordingly.

If you believe that copyright or intellectual property rights have been infringed by the presentation, please contact us immediately to clarify your concerns.